<DOC>
	<DOCNO>NCT02545582</DOCNO>
	<brief_summary>This registry observe patient symptomatic heart failure implantable vagus nerve stimulation provide insight safety efficacy clinical routine .</brief_summary>
	<brief_title>VITARIA Registry Study</brief_title>
	<detailed_description>Observational prospective clinical registry patient symptomatic heart failure implant VITARIA System . Assessments make 12 month post-titration chronic stimulation . The registry collect patient- device follow-up data clinical routine practice baseline , 3 , 6 12 month . Clinical routine safety therapy assess incidence procedure device-related event . Clinical routine efficacy assess change cardiac function heart failure symptom .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . Willing capable providing inform consent accord national data privacy regulation 2 . Patients NYHA class II/III 3 . LVEFâ‰¤40 % image method echocardiography , radionuclide angiography , leave ventriculography , cardiac magnetic resonance imaging , document less 12 week implantation VITARIA system 4 . Receiving optimal pharmacological heart failure therapy least 3 month 5 . Recent implantation VITARIA system , prior device activation 1 . Hospitalization heart failure and/or require use Heart Failure intravenous therapy past 30 day 2 . Severe mitral and/or aortic valve dysfunction 3 . History acute coronary syndrome ( ACS ) past 90 day 4 . Stroke transient ischemic attack ( TIA ) past 90 day 5 . Coronary Artery Bypass Surgery ( CABG ) past 90 day 6 . PCI past 90 day 7 . Surgery Valve replacement ( Aortic mitral valve ) past 90 day 8 . Left ventricular end diastolic diameter ( LVEDD ) &gt; 80 mm 9 . Patients cardiac resynchronization therapy ( CRT ) device implant actively treat CRT &lt; 12 month 10 . Patients schedule CRT 11 . Patients listed heart transplant expect candidate heart transplant 12 . Patients hemodialysis peritoneal dialysis 13 . Patients diabetes ( type I type II ) medically treat autonomic sensory neuropathy , measure hemoglobin A1c ( HbA1c ) 8.0 % past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>